Jillian Cornish
Department of Medicine
University of Auckland
Auckland
New Zealand
Name/email consistency: high
- Modulation of osteoclastogenesis by fatty acids. Cornish, J., MacGibbon, A., Lin, J.M., Watson, M., Callon, K.E., Tong, P.C., Dunford, J.E., van der Does, Y., Williams, G.A., Grey, A.B., Naot, D., Reid, I.R. Endocrinology (2008)
- Preptin, another peptide product of the pancreatic beta-cell, is osteogenic in vitro and in vivo. Cornish, J., Callon, K.E., Bava, U., Watson, M., Xu, X., Lin, J.M., Chan, V.A., Grey, A.B., Naot, D., Buchanan, C.M., Cooper, G.J., Reid, I.R. Am. J. Physiol. Endocrinol. Metab. (2007)
- Lactoferrin and bone; structure-activity relationships. Cornish, J., Palmano, K., Callon, K.E., Watson, M., Lin, J.M., Valenti, P., Naot, D., Grey, A.B., Reid, I.R. Biochem. Cell Biol. (2006)
- Shared pathways of osteoblast mitogenesis induced by amylin, adrenomedullin, and IGF-1. Cornish, J., Grey, A., Callon, K.E., Naot, D., Hill, B.L., Lin, C.Q., Balchin, L.M., Reid, I.R. Biochem. Biophys. Res. Commun. (2004)
- Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Cornish, J., Callon, K.E., Naot, D., Palmano, K.P., Banovic, T., Bava, U., Watson, M., Lin, J.M., Tong, P.C., Chen, Q., Chan, V.A., Reid, H.E., Fazzalari, N., Baker, H.M., Baker, E.N., Haggarty, N.W., Grey, A.B., Reid, I.R. Endocrinology (2004)
- Lactoferrin promotes bone growth. Cornish, J. Biometals (2004)
- alpha -melanocyte-stimulating hormone is a novel regulator of bone. Cornish, J., Callon, K.E., Mountjoy, K.G., Bava, U., Lin, J.M., Myers, D.E., Naot, D., Reid, I.R. Am. J. Physiol. Endocrinol. Metab. (2003)
- Interleukin-18 is a novel mitogen of osteogenic and chondrogenic cells. Cornish, J., Gillespie, M.T., Callon, K.E., Horwood, N.J., Moseley, J.M., Reid, I.R. Endocrinology (2003)
- Adrenomedullin--a regulator of bone formation. Cornish, J., Naot, D., Reid, I.R. Regul. Pept. (2003)
- Amylin and adrenomedullin: novel regulators of bone growth. Cornish, J., Naot, D. Curr. Pharm. Des. (2002)
- Leptin directly regulates bone cell function in vitro and reduces bone fragility in vivo. Cornish, J., Callon, K.E., Bava, U., Lin, C., Naot, D., Hill, B.L., Grey, A.B., Broom, N., Myers, D.E., Nicholson, G.C., Reid, I.R. J. Endocrinol. (2002)
- Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Cornish, J., Callon, K.E., Bava, U., Kamona, S.A., Cooper, G.J., Reid, I.R. Bone (2001)
- Effects of amylin and adrenomedullin on the skeleton. Cornish, J., Reid, I.R. J. Musculoskelet. Neuronal. Interact (2001)
- Systemic administration of a novel octapeptide, amylin-(1---8), increases bone volume in male mice. Cornish, J., Callon, K.E., Gasser, J.A., Bava, U., Gardiner, E.M., Coy, D.H., Cooper, G.J., Reid, I.R. Am. J. Physiol. Endocrinol. Metab. (2000)
- Trifluoroacetate, a contaminant in purified proteins, inhibits proliferation of osteoblasts and chondrocytes. Cornish, J., Callon, K.E., Lin, C.Q., Xiao, C.L., Mulvey, T.B., Cooper, G.J., Reid, I.R. Am. J. Physiol. (1999)
- Leukemia inhibitory factor is mitogenic to osteoblasts. Cornish, J., Callon, K.E., Edgar, S.G., Reid, I.R. Bone (1997)